Induction chemotherapy, surgical resection, and high-dose chemotherapy for mediastinal nonseminomatous germ-cell tumor

被引：1
|
作者：
Date, H
Kiura, K
Ueoka, H
Tabata, M
Hotta, K
Katayama, H
Kataoka, I
Tanimoto, M
机构：
[1] Okayama Univ, Grad Sch Med & Dent, Dept Canc & Thorac Surg, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med & Dent, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 130卷 / 04期
关键词：
D O I：
10.1016/j.jtcvs.2005.06.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1205 / 1206
页数：2
相关论文
共 50 条
  • [1] Consolidation high-dose chemotherapy for patients with primary mediastinal nonseminomatous germ cell tumor
    Banna, G. L.
    De Giorgi, U.
    Ferrari, B.
    Castagna, L.
    Alloisio, M.
    Marangolo, M.
    Rosti, G.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI75 - XI75
  • [2] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Kessler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna, Giuseppe Luigi
    De Giorgi, Ugo
    Ferrari, Benvenuto
    Castagna, Luca
    Alloisio, Marco
    Marangolo, Maurizio
    Rosti, Giovanni
    Santoro, Armando
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (10) : 1085 - 1091
  • [4] Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy
    Chou, Jia-Ling
    Tse, David
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 1254 - 1260
  • [5] High-dose chemotherapy in nonseminomatous germ cell cancer
    Kollmannsberger, Christian
    Beyer, Joerg
    Bokemeyer, Carsten
    BJU INTERNATIONAL, 2009, 104 (9B) : 1398 - 1403
  • [6] ADJUVANT CHEMOTHERAPY IN NONSEMINOMATOUS GERM-CELL TUMOR
    CLEMM, C
    MAIR, W
    HARTENSTEIN, R
    STAEHLER, G
    WIESEL, M
    GERL, A
    WILMANNS, W
    BLUT, 1988, 57 (04): : 246 - 246
  • [7] CONSOLIDATION TREATMENT OF HIGH-RISK NONSEMINOMATOUS GERM-CELL TUMOR (NSGCT) WITH HIGH-DOSE CHEMOTHERAPY AND ABMT
    WANDT, H
    BIRKMANN, J
    SEIFERT, M
    MEISNER, M
    ZIMBER, J
    GALLMEIER, WM
    BONE MARROW TRANSPLANTATION, 1992, 10 : 58 - 58
  • [8] High-dose chemotherapy in germ-cell tumors
    Droz, JP
    Culine, S
    Biron, P
    Kramar, A
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 997 - 1003
  • [9] SALVAGE THERAPY WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT IN THE TREATMENT OF PRIMARY NONSEMINOMATOUS MEDIASTINAL GERM-CELL TUMORS
    BROUN, ER
    NICHOLS, CR
    EINHORN, LH
    TRICOT, GJK
    CANCER, 1991, 68 (07) : 1513 - 1515
  • [10] HIGH-DOSE CISPLATINUM COMBINATION CHEMOTHERAPY IN ADVANCED NONSEMINOMATOUS MALIGNANT GERM-CELL TUMORS WITH EMPHASIS ON NEPHROTOXICITY
    HALL, KS
    FOSSA, SD
    AAS, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 74 - 77
12345